IBL HealthCare Limited has released its financial results for the quarter ended September 30, 2026, reporting a decline in profitability compared to the previous year.
- Reporting Period: Quarter ended September 30, 2026 (Un-audited)
- Revenue: PKR 1,121.19M (+0.2% YoY)
- Gross Profit: PKR 391.85M (+23.1% YoY)
- Operating Profit: PKR 92.65M (-30.1% YoY)
- Finance Cost: PKR 1.00M (down from PKR 9.20M YoY)
- Net Profit (PAT): PKR 64.05M (-8.1% YoY)
- EPS: PKR 0.65 (down from PKR 0.71 YoY)
- Cash Dividend: Nil
- Bonus Shares: Nil
- Main driver: Decrease in operating profit due to increased marketing and distribution expenses.